PROCEPT BioRobotics Corporation Faces Securities Fraud Lawsuit
Investor rights law firm Rosen Law Firm has initiated a class action lawsuit against PROCEPT BioRobotics Corporation. The suit alleges securities fraud related to the company's stock.
NEW YORK, Aug. 3, 2026 – Rosen Law Firm, a global investor rights law firm, announced the filing of a class action lawsuit on behalf of purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock. The lawsuit covers the period between February 28, 2024, and February 25, 2026, inclusive.
The complaint alleges that the company made materially false and misleading statements and failed to disclose important information to investors. Specifically, the suit points to risks associated with the company's business operations that were allegedly not properly communicated.
Rosen Law Firm is seeking investors who purchased PRCT stock during the specified class period and suffered losses to come forward. The firm is investigating potential violations of federal securities laws by PROCEPT BioRobotics Corporation.
The filing of this lawsuit is part of broader efforts to hold companies accountable for transparency and accurate disclosure to the investing public. PROCEPT BioRobotics Corporation has not yet issued a public statement regarding the lawsuit.